Thursday - January 22, 2026

Marginal Zone Lymphoma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison

The Key Marginal Zone Lymphoma Companies in the market include – Bristol-Myers Squibb, TG Therapeutics, Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma, Beigene, Incyte Corporation, Enterome, and others. DelveInsight’s “Marginal Zone Lymphoma Market Insights, Epidemiology, … Continue reading

Retinitis Pigmentosa Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Biogen, Neurotech, Ionis Pharma, Nacuity Pharma, Allegro Ophthalmics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Retinitis Pigmentosa pipeline constitutes 40+ key companies continuously working towards developing 40+ Retinitis Pigmentosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

OZEMPIC A Comprehensive Forecast on the Accelerating Market Growth for Type 2 Diabetes by 2032

Explore DelveInsight’s comprehensive report on OZEMPIC (Novo Nordisk), offering detailed market insights, sales forecasts, and market size analysis up to 2034.” [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on OZEMPIC … Continue reading

Refractory Metastatic Melanoma Clinical Trial Pipeline Accelerates as 4+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Refractory Metastatic Melanoma Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory Metastatic Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading